Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:795-801

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larouche, I.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larouche, I.
Right arrow Articles by Schiffrin, E. L.

(Hypertension. 1999;34:795-801.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Cardiac Microvasculature in DOCA-Salt Hypertensive Rats

Effect of Endothelin ETA Receptor Antagonism

Isabelle Larouche; Ernesto L. Schiffrin

From the MRC Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montréal, Montréal, Quebec, Canada.

Correspondence to Ernesto L. Schiffrin, MD, PhD, FRCPC, Clinical Research Institute of Montreal, 110 Avenue des Pins Ouest, Montréal, Québec, Canada H2W 1R7. E-mail schiffe{at}ircm.qc.ca

Abstract—The cardiac abnormalities associated with hypertension include left ventricular hypertrophy and vascular changes. The latter may affect the cardiac microvasculature and predispose to myocardial ischemia. To test the hypothesis that endothelin-1 contributes to changes in the microcirculation of the heart, we studied cardiac microvessels of the deoxycorticosterone acetate–salt (DOCA-salt) model of hypertension in the rat, in which the endothelin system is activated, and the effect of the endothelin-A (ETA) subtype–selective endothelin receptor antagonist A-127722. A-127722 (30 mg · kg-1 · d-1) was administered for 4 weeks. Arterioles (<=20 µm in lumen diameter) were identified in the myocardium by use of immunolabeling with an anti–smooth muscle {alpha}-actin antibody, and capillaries with an anti-laminin antibody with nuclear counterstaining by nuclear fast red. Systolic blood pressure was 103±1.6 mm Hg in unilaterally nephrectomized rats (UniNx), 202±3.2 mm Hg in DOCA-salt (P<0.01 versus UniNx), and 182±3.1 mm Hg in ETA antagonist–treated DOCA-salt (P<0.01 versus DOCA-salt or UniNx). Arteriolar and capillary densities were altered significantly in the subendocardial myocardium but not in the subepicardial myocardium of the left ventricle. Arteriolar density per square millimeter was 18.1±1.48 in UniNx, 31.9±3.26 in DOCA-salt (P<0.01 versus UniNx), and 24.2±1.36 in ETA antagonist–treated DOCA-salt (P<0.05 versus DOCA-salt or UniNx). Capillary density per square millimeter was 2395±148 in UniNx, 1576±107 in DOCA-salt (P<0.01 versus UniNx), and 1982±31 in ETA antagonist–treated DOCA-salt (P<0.01 versus DOCA-salt or UniNx). In conclusion, in DOCA-salt hypertensive rats, subendocardial arteriolar growth and capillary rarefaction were observed in the left ventricular myocardium, and both were partially corrected by ETA receptor antagonism. This suggests a role for endothelin-1 in cardiac arteriolar growth and capillary rarefaction, which may have pathophysiological implications by contributing to myocardial ischemia in hypertension.


Key Words: microcirculation • arterioles • growth • capillaries • hypertension, experimental • myocardium • ischemia




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Iemitsu, S. Maeda, S. Jesmin, T. Otsuki, and T. Miyauchi
Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1290 - H1298.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Kobayashi, F. A. DeLano, and G. W. Schmid-Schonbein
Oxidative Stress Promotes Endothelial Cell Apoptosis and Loss of Microvessels in the Spontaneously Hypertensive Rats
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2114 - 2121.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Iglarz, R. M. Touyz, F. Amiri, M.-F. Lavoie, Q. N. Diep, and E. L. Schiffrin
Effect of Peroxisome Proliferator-Activated Receptor-{alpha} and -{gamma} Activators on Vascular Remodeling in Endothelin-Dependent Hypertension
Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 45 - 51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. D. Giulumian, M. M. Molero, V. B. Reddy, J. S. Pollock, D. M. Pollock, and L. C. Fuchs
Role of ET-1 receptor binding and [Ca2+]i in contraction of coronary arteries from DOCA-salt hypertensive rats
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1944 - H1949.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. L. Schiffrin
Role of Endothelin-1 in Hypertension
Hypertension, October 1, 1999; 34(4): 876 - 881.
[Abstract] [Full Text] [PDF]